FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) in Relapsed Patients

Mise à jour : Il y a 4 ans
Référence : NCT00090051

Femme et Homme

Extrait

The purpose of this study is to provide treatment for patients who have chronic lymphocytic leukemia (CLL), and to compare the use of rituximab added to fludarabine+cyclophosphamide (FC) with FC alone, to determine if rituximab lengthens the time a patient remains free of leukemia symptoms.


Critère d'inclusion

  • Chronic lymphocytic leukemia


Liens